查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1616777

基因检测市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Genetic Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 136 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球基因检测市场价值为186 亿美元，预计2024 年至2032 年间将以12.3% 的复合年增长率强劲增长。的生物资讯学工具，显着提高了基因检测的准确性、效率和可负担性。此外，基因检测与数位健康平台和电子健康记录的整合使基因资讯更容易取得和操作，增强了其在临床和消费者健康环境中的效用。消费者发起的基因检测服务和产品的不断增加也促进了市场的成长。这些服务为个人提供了对其遗传健康风险的个人化见解，使遗传讯息更加用户友好，并得到个人化健康报告和遗传咨询等工具的支持。

此外，旨在加速基因组学领域技术创新的持续研究经费预计将推动基因检测产业的持续扩张。就产品和服务而言，市场分为试剂盒和试剂以及软体和服务。 2023 年，试剂盒和试剂细分市场占据主导地位，收入达 121 亿美元。特别是次世代定序(NGS) 试剂盒的需求量很大，因为它们能够对整个基因组或特定区域进行定序，从而促进全面的遗传分析。提供试剂：样本库製备、定序和资料分析。按测试类型分类时，市场包括预测测试、携带者测试、产前和新生儿测试、诊断测试、药物基因组学、营养基因组学等。到2023 年，产前和新生儿检测领域以39.6% 的份额引领市场。发现遗传性疾病没有与侵入性手术相关的风险。从地区来看，北美拥有最大的市场份额，到2023 年将占46.3%。对基因的高度认识疾病及其治疗方案也推动了北美对基因检测服务和产品的需求，使其成为全球市场成长轨蹟的关键参与者。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 186 亿美元
预测值 523 亿美元
复合年增长率 12.3%

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 技术进步和新测试的可用性
      • 基因检测在肿瘤学和遗传疾病的应用日益广泛
      • 消费者对个人化医疗的偏好不断增加
      • 对直接面向消费者的基因检测的需求不断增长
    • 产业陷阱与挑战
      • 基因检测费用高
      • 发展中经济体和已开发经济体缺乏经验丰富的专业人员和先进的基础设施
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 报销场景
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪錶板

第 5 章：市场估计与预测：按产品和服务分类，2021 - 2032 年

  • 主要趋势
  • 试剂盒和试剂
  • 软体与服务

第 6 章：市场估计与预测：按测试类型，2021 - 2032

  • 主要趋势
  • 预测测试
  • 运营商测试
  • 产前和新生儿检测
  • 诊断测试
  • 药物基因组测试
  • 营养基因体学
  • 其他测试类型

第 7 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 癌症治疗
  • 移植组织分型
  • 法医身分测试
  • 血统测试
  • 亲子鑑定
  • 其他应用

第 8 章：市场估计与预测：按技术分类，2021 - 2032 年

  • 主要趋势
  • 聚合酶炼式反应
  • DNA定序
    • 桑格定序
    • 下一代定序
  • 细胞遗传学检测
    • 染色体分析（核型分析）
    • 萤光原位杂交（FISH）
  • 微阵列
  • 基因表现谱

第 9 章：市场估计与预测：依最终用途，2021 - 2032 年

  • 主要趋势
  • 医院和诊所
  • 诊断实验室
  • 法医实验室
  • 其他最终用户

第 10 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 11 章：公司简介

  • 23 and ME, Inc.
  • Abbott Laboratories
  • Ambry genetics
  • Ancestry DNA
  • bioMerieux SA
  • BGI Genomics
  • Illumina, Inc.
  • Invitae Corporation
  • Luminex Corporation
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • QIAGEN NV
  • Quest Diagnostics
  • Siemens Healthineers AG
简介目录
Product Code: 2490

The Global Genetic Testing Market was valued at USD 18.6 billion in 2023 and is projected to grow at a robust CAGR of 12.3% between 2024 and 2032. This growth is driven by advancements in genomics, such as high-throughput sequencing technologies and enhanced bioinformatics tools, which have significantly improved the accuracy, efficiency, and affordability of genetic testing. Additionally, the integration of genetic testing with digital health platforms and electronic health records has made genetic information more accessible and actionable, enhancing its utility in both clinical and consumer health settings. The increasing availability of consumer-initiated genetic testing services and products is also contributing to market growth. These services provide individuals with personalized insights into their genetic health risks, making genetic information more user-friendly and supported by tools like personalized health reports and access to genetic counseling.

Further, ongoing research funding aimed at accelerating technological innovation in the genomics sector is expected to drive continued expansion in the genetic testing industry. In terms of products and services, the market is segmented into kits & reagents and software & services. The kits & reagents segment dominated the market in 2023, generating USD 12.1 billion in revenue. Next-generation sequencing (NGS) kits, in particular, are in high demand due to their ability to sequence entire genomes or specific regions, facilitating comprehensive genetic analysis.These kits are critical for both clinical diagnostics and research, offering reagents for processes such as library preparation, sequencing, and data analysis. When classified by test type, the market includes predictive testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomics, nutrigenomics, and others. The prenatal and newborn testing segment led the market with a 39.6% share in 2023. This segment's dominance is driven by the growing adoption of advanced screening methods, such as non-invasive prenatal testing (NIPT), which allow for early detection of genetic disorders without the risks associated with invasive procedures. Regionally, North America held the largest market share, accounting for 46.3% in 2023. The region's dominance is supported by a strong presence of key market players, advanced healthcare infrastructure, and leading research institutions focused on genetic research.High levels of awareness about genetic disorders and their treatment options also drive the demand for genetic testing services and products in North America, positioning it as a key player in the global market growth trajectory.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$18.6 Billion
Forecast Value$52.3 Billion
CAGR12.3%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Technological advancement and availability of new tests
      • 3.2.1.2 Growing application of genetic testing in oncology and genetic diseases
      • 3.2.1.3 Increasing consumer preference for personalized medicine
      • 3.2.1.4 Growing demand for direct-to-consumer genetic testing
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of genetic testing
      • 3.2.2.2 Dearth of experienced professionals and advanced infrastructure in developing and developed economies
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Products & Services, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Kits & reagents
  • 5.3 Software & services

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Predictive testing
  • 6.3 Carrier testing
  • 6.4 Prenatal and newborn testing
  • 6.5 Diagnostic testing
  • 6.6 Pharmacogenomic testing
  • 6.7 Nutrigenomics
  • 6.8 Other test types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cancer treatment
  • 7.3 Tissue typing for transplantation
  • 7.4 Forensic identity testing
  • 7.5 Ancestry testing
  • 7.6 Paternity testing
  • 7.7 Other applications

Chapter 8 Market Estimates and Forecast, By Techniques, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Polymerase chain reaction
  • 8.3 DNA sequencing
    • 8.3.1 Sanger sequencing
    • 8.3.2 Next generation sequencing
  • 8.4 Cytogenetic testing
    • 8.4.1 Chromosome analysis (karyotyping)
    • 8.4.2 Fluorescence in situ hybridization (FISH)
  • 8.5 Microarrays
  • 8.6 Gene expression profiling

Chapter 9 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Hospitals & clinics
  • 9.3 Diagnostic laboratories
  • 9.4 Forensic laboratories
  • 9.5 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

  • 11.1 23 and ME, Inc.
  • 11.2 Abbott Laboratories
  • 11.3 Ambry genetics
  • 11.4 Ancestry DNA
  • 11.5 bioMerieux SA
  • 11.6 BGI Genomics
  • 11.7 Illumina, Inc.
  • 11.8 Invitae Corporation
  • 11.9 Luminex Corporation
  • 11.10 Myriad Genetics, Inc.
  • 11.11 Natera, Inc.
  • 11.12 QIAGEN N.V.
  • 11.13 Quest Diagnostics
  • 11.14 Siemens Healthineers AG